BioRestorative Therapies Inc. (BRTX) Stock Price, Quote & News

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

BioRestorative Therapies ... (BRTX)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

1.81

0.00 (0.00%)

At close: Jan 15, 2025, 3:59 PM

1.80

-0.55%

After-hours Jan 15, 2025, 04:00 PM EST

undefined% (undefined)

Bid	1.77
Market Cap	12.53M
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	-2.38
PE Ratio (ttm)	-0.76
Forward PE	n/a
Analyst	Strong Buy

Ask	1.85
Volume	66,092
Avg. Volume (20D)	56,780
Open	1.83
Previous Close	1.81
Day's Range	1.77 - 1.85
52-Week Range	1.03 - 3.67
Beta	undefined

About BRTX

BioRestorative Therapies, Inc., a life sciences company, focuses on the development of regenerative medicine products and therapies using cell and tissue protocols primarily involving adult stem cells. The company's two core developmental programs relate to the treatment of disc/spine disease and metabolic disorders. Its disc/spine program (brtxDisc) includes a lead cell therapy candidate, BRTX-100, a product candidate formulated from autologous ...

[Show more]

Industry Biotechnology

Sector Healthcare

IPO Date Dec 5, 2012

Employees 11

Stock Exchange NASDAQ

Ticker Symbol BRTX

Website https://www.biorestorative.com

Analyst Forecast

According to 1 analyst ratings, the average rating for BRTX stock is "Strong Buy." The 12-month stock price forecast is $18, which is an increase of 894.48% from the latest price.

Buy 100.00%

Hold 0.00%

Sell 0.00%

Stock Forecasts

Next Earnings Release

BioRestorative Therapies Inc. is scheduled to release its earnings on Mar 28, 2025, before market opens.
Analysts project revenue of $475.00K, reflecting a 2.36K% YoY growth and earnings per share of -0.27, making a -52.63% decrease YoY.

Why Price Moved

7 months ago · Source

+20%

BioRestorative Therapies shares are trading higher... Unlock content with Pro Subscription

7 months ago · Source

+44.44%

BioRestorative Therapies shares are trading higher after the company announced that it engaged in advanced discussions for a ThermoStem license with a regenerative medicine firm.

News

2 months ago · seekingalpha.com

BioRestorative Therapies, Inc. (BRTX) Q3 2024 Earnings Call Transcript

BioRestorative Therapies, Inc. (NASDAQ:BRTX ) Q3 2024 Earnings Conference Call November 13, 2024 4:30 PM ET Company Participants Stephen Kilmer – Investor Relations Lance Alstodt – Chairman and Chief ...